rfhg_146322.1

Basic information about the TSS

---

TSS ID: rfhg_146322.1 Species: human Chr: chr12		Start: 6602964 End: 6602965 Strand: -
Source datasets	PRJNA4843412
Protocol	NETCAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000430771.2:-177 GeneID: 1108 HGNC/MGI_ID: HGNC:1919 UniProt_ID: Nearer transcript ids and distances:

Gene_name: chromodomain helicase DNA binding protein 4 Gene_symbol: CHD4 Gene_synonyms: Mi-2b Mi2-BETA Gene_source: HGNC:1919

TATA-Box annotation

---

Distance to TSS:	3487
Nearest PromoterID:	NM_001297553
Entrez ID:	1108
Nearest Unigene:	Hs.162233
Nearest Refseq:	NM_001273
Nearest Ensembl:	ENSG00000111642
Gene Name:	chromodomain helicase DNA binding protein 4
Gene Alias:	CHD-4|Mi-2b|Mi2-BETA|SIHIWES
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.500000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CHD4 p2@CHD4 p3@CHD4 p4@CHD4 p5@CHD4
Sample		p1@CHD4	p2@CHD4	p3@CHD4	p4@CHD4	p5@CHD4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	78.12	15.97	2.14	0.58	3.70
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	69.40	15.38	2.63	0.81	4.05
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	78.32	13.12	2.51	0.58	3.67
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	73.81	12.68	3.74	1.25	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	72.66	11.47	2.70	0.00	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	68.80	12.79	3.10	0.19	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	99.35	11.98	3.05	0.22	4.14
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	90.11	11.14	3.15	0.73	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	94.89	13.46	1.50	0.64	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	170.41	6.96	0.58	0.00	2.32
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	143.10	8.89	0.40	0.40	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	169.94	7.72	0.81	0.41	2.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	143.78	16.76	2.58	6.13	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	121.93	10.22	3.16	4.51	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	119.44	12.29	3.51	6.15	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	113.93	13.58	2.77	4.02	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	95.23	9.61	2.62	6.33	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	107.56	12.23	2.95	6.75	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	102.37	14.93	0.53	7.46	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	126.82	12.94	2.56	6.62	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	112.40	14.30	1.60	5.35	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	127.22	14.33	2.76	5.52	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	106.90	11.63	3.10	5.69	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	107.99	11.65	0.24	4.37	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	119.19	12.90	4.90	6.45	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	116.79	9.50	2.53	4.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	120.88	18.68	1.65	7.69	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	157.72	15.32	2.59	6.84	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	118.24	15.02	2.10	3.55	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	129.57	15.38	1.63	4.71	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	108.65	13.82	2.09	5.44	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	129.54	11.14	3.71	5.86	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	103.19	11.82	2.95	3.80	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	104.74	12.54	1.65	2.80	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	120.42	11.03	2.99	3.37	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	128.00	10.92	3.26	4.60	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	120.58	8.58	1.64	7.56	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	110.62	8.87	1.21	3.83	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	109.39	9.99	1.08	2.16	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	104.19	8.88	1.68	2.64	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	90.34	8.94	1.88	6.35	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	99.26	11.13	1.90	3.22	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	124.22	8.44	1.90	3.37	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	116.61	12.59	3.50	3.50	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	129.90	9.24	1.61	5.42	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	128.89	10.47	1.63	6.28	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	111.08	8.88	0.96	4.80	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	115.64	8.35	2.09	3.87	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	116.58	7.42	1.91	3.11	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	141.13	7.68	2.02	5.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	149.41	11.89	1.84	2.46	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	144.54	8.67	1.78	3.56	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	727.59	83.95	27.98	0.00	55.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	85.17	3.90	1.06	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	84.83	5.96	0.66	1.66	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	243.29	10.91	2.52	1.68	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	144.20	6.43	0.92	0.92	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	96.91	3.89	0.00	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	91.85	5.46	0.64	1.93	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	200.23	8.49	0.63	1.26	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	117.04	1.41	0.71	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	84.12	5.05	0.56	1.12	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	344.73	13.53	3.18	0.00	3.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	197.41	9.51	0.00	0.34	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	138.09	2.92	1.30	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	95.84	6.03	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	711.21	32.33	32.33	0.00	64.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	710.77	39.49	0.00	0.00	47.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	84.34	3.41	0.98	1.95	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	91.24	1.49	1.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	66.61	4.22	0.47	0.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	106.31	8.28	0.66	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	82.59	4.64	0.62	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	73.38	4.89	0.00	0.92	0.92
Adipocyte - breast, donor1	11376-118A8	21.07	4.12	1.58	1.90	0.32
Adipocyte - breast, donor2	11327-117E4	28.88	5.29	1.93	2.89	0.16
Adipocyte - omental, donor1	11473-119C6	23.92	4.45	5.22	4.58	0.25
Adipocyte - omental, donor2	11474-119C7	16.44	2.99	0.00	2.24	0.75
Adipocyte - omental, donor3	11475-119C8	19.43	3.01	0.67	1.67	0.33
Adipocyte - perirenal, donor1	11476-119C9	15.31	3.19	1.28	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	8.80	1.10	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	21.68	2.26	2.26	1.35	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	18.94	3.30	1.39	1.39	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	83.31	10.95	2.54	2.93	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	54.56	10.81	2.06	2.06	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	78.61	9.20	1.39	1.95	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	57.61	11.76	2.94	4.70	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	58.07	8.45	1.29	1.93	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	59.06	7.75	0.97	3.23	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	49.05	6.93	2.67	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	38.95	7.23	1.11	3.90	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	42.01	3.74	1.66	1.25	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	39.68	4.77	1.26	1.76	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	42.21	5.56	0.98	4.25	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	45.98	7.31	2.44	2.44	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	27.62	6.85	1.33	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	24.74	3.59	0.36	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	14.38	7.19	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	40.12	10.79	0.18	1.44	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	60.25	11.71	1.67	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	52.18	8.42	1.23	0.82	0.62
Anulus Pulposus Cell, donor1	11248-116E6	42.45	8.81	1.83	1.14	0.57
Anulus Pulposus Cell, donor2	11463-119B5	41.39	4.90	0.73	2.20	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	35.05	3.59	0.45	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	29.52	2.60	0.43	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	26.60	5.08	0.60	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	26.56	5.06	0.00	0.00	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	16.50	1.32	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	22.09	2.92	0.00	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	21.84	2.91	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.22	1.19	0.00	0.00	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	32.39	4.52	0.00	0.75	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	32.66	2.90	0.00	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	17.46	2.31	0.49	0.49	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	25.93	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.74	1.96	0.15	0.00	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	30.00	3.75	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	25.70	3.02	0.76	0.19	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	24.59	3.21	0.27	0.80	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	25.36	4.88	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	27.20	2.82	0.33	0.50	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	3.60	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	7.08	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	33.96	3.43	0.86	1.03	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	38.83	4.37	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	31.87	3.79	1.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	25.44	2.42	2.42	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	26.79	6.27	1.14	0.57	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	33.14	4.06	0.64	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	18.84	2.84	0.00	0.52	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	27.68	5.16	0.94	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	24.12	2.57	0.00	0.32	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	19.26	2.85	0.00	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	28.08	2.92	0.00	0.00	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	24.09	3.01	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	3.56	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	35.60	2.03	1.02	1.53	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	32.35	4.84	0.76	0.25	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	15.25	2.54	0.64	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	34.95	3.88	0.86	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	25.40	1.48	0.42	1.06	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	20.88	2.03	0.00	0.00	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	33.07	1.89	0.00	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	27.80	2.03	0.51	0.34	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	44.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	26.80	3.65	0.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	20.46	4.21	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	29.16	4.37	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	33.33	2.07	1.38	1.15	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	38.25	2.55	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	15.51	1.27	0.25	0.51	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	33.03	2.27	0.21	0.62	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	29.38	1.53	0.61	0.31	1.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	36.81	2.87	0.96	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	30.60	3.99	0.22	0.44	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	3.05	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	26.03	3.32	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	28.86	2.38	0.26	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	18.54	2.18	0.36	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	32.91	13.63	1.47	1.72	0.61
Astrocyte - cerebellum, donor2	11580-120F5	37.14	8.04	0.68	1.54	0.00
Astrocyte - cerebellum, donor3	11661-122F5	31.88	5.87	1.05	1.47	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	53.68	19.87	0.35	2.79	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	79.43	16.18	4.04	2.43	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	74.88	11.63	1.94	0.89	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	128.91	10.32	4.70	0.46	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	135.81	12.28	4.64	0.75	2.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	135.30	13.31	4.10	0.57	2.05
Basophils, donor1	12241-129G9	39.75	11.51	5.23	1.05	0.26
Basophils, donor2	12242-129H1	57.01	16.24	12.27	2.16	0.36
Basophils, donor3	12243-129H2	39.54	8.38	3.23	0.59	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	27.81	4.53	0.00	0.43	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	17.83	3.66	0.00	0.46	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	25.11	1.88	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	54.07	3.54	0.42	0.62	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	33.85	3.68	0.23	0.23	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	27.71	7.38	0.54	1.26	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	66.06	15.56	5.67	0.93	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	107.60	17.23	2.10	0.47	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	102.65	17.59	3.52	1.28	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	51.71	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	69.88	12.40	6.20	1.69	0.56
CD14+ Monocytes, donor2	11305-117B9	95.03	10.76	6.50	1.67	2.41
CD14+ Monocytes, donor3	11381-118B4	65.86	13.17	7.24	1.10	2.20
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	53.78	11.89	0.28	3.11	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	61.41	14.40	0.76	2.27	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	65.09	7.56	0.00	2.63	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	39.46	5.93	0.43	0.87	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	36.51	7.54	1.51	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	52.35	9.71	0.71	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	45.87	6.03	0.00	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	48.58	5.24	0.00	0.00	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	55.78	3.22	0.99	0.50	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	31.13	3.92	0.78	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	34.01	2.49	0.71	0.71	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	34.60	2.83	1.31	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	44.02	6.09	0.70	0.94	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	61.25	7.39	2.11	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	45.48	6.66	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	34.06	5.95	0.30	0.15	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	33.52	4.59	0.40	0.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	38.31	4.58	0.83	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	47.82	3.20	0.46	0.46	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	33.25	5.20	1.36	0.90	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	50.63	3.49	0.44	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	24.48	5.65	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	27.39	4.19	0.70	0.52	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	37.45	3.37	1.26	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	47.40	3.31	0.18	0.37	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	69.75	5.28	0.70	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	91.69	4.39	0.44	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	28.25	5.23	0.35	0.87	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	30.48	5.58	1.12	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	38.15	4.74	0.43	1.29	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	60.19	4.91	0.82	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	47.52	3.48	0.70	1.16	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	57.07	4.18	0.23	0.23	0.70
CD14+CD16+ Monocytes, donor1	11789-124B7	22.45	8.28	0.87	0.00	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	39.73	9.01	0.23	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	20.15	8.01	0.22	0.22	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	47.03	14.17	2.18	0.78	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	42.96	8.91	1.05	0.35	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	80.94	24.08	1.34	0.45	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	25.52	8.42	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	28.32	6.59	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	22.53	10.32	0.00	0.42	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	83.32	22.36	2.03	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	75.26	12.20	3.39	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	55.92	16.57	3.11	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	60.23	18.66	2.13	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	83.63	13.94	3.75	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	75.81	11.93	0.70	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	56.47	21.96	3.14	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	79.10	15.82	2.64	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	121.64	22.19	5.75	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	121.87	13.78	2.90	0.00	1.45
CD19+ B Cells, donor3	11705-123B4	123.68	13.13	4.54	0.00	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	32.73	13.74	2.02	0.40	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	16.38	12.78	0.80	1.20	0.80
CD34+ Progenitors, donor1	11545-120B6	64.26	13.05	6.02	1.00	2.01
CD34+ Progenitors, donor2	11625-122B5	87.64	14.05	7.87	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	60.50	13.15	3.38	1.88	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	83.88	18.94	7.67	1.13	0.23
CD4+ T Cells, donor1	11225-116C1	67.84	16.07	11.07	2.14	0.36
CD4+ T Cells, donor2	11306-117C1	90.02	6.12	12.25	0.00	1.84
CD4+ T Cells, donor3	11382-118B5	57.64	12.50	9.76	2.74	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	59.98	18.89	4.08	2.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	43.12	19.09	3.59	1.57	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	46.86	19.55	7.76	2.87	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	36.51	12.80	15.65	3.79	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	25.99	11.24	16.15	0.70	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	62.63	16.48	16.48	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	44.08	15.75	2.46	0.58	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	51.18	12.37	3.73	2.03	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	45.46	8.71	2.74	1.77	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	33.62	12.55	16.59	1.34	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	41.58	12.23	6.99	1.40	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	46.20	18.48	18.04	2.20	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	45.12	19.40	7.59	0.42	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	47.99	11.64	2.70	0.62	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	40.10	8.35	2.00	0.67	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	41.88	13.32	17.13	1.36	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	52.52	17.69	14.47	2.14	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	43.04	12.55	23.31	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	56.37	14.65	4.82	1.67	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	51.34	13.43	2.17	0.65	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	48.33	14.71	2.31	0.42	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	50.56	17.70	8.09	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	26.43	16.90	6.50	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	54.91	20.05	10.02	1.31	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	60.37	23.75	8.91	1.98	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	36.00	21.23	14.77	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	46.06	15.35	13.96	2.79	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	54.00	25.20	13.02	1.94	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	75.09	23.56	19.39	3.19	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	47.74	23.10	9.24	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	70.19	25.43	11.10	2.86	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	48.47	27.70	5.54	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	66.79	17.02	19.64	2.62	0.98
CD8+ T Cells, donor2	11307-117C2	131.40	14.64	20.65	1.88	1.88
CD8+ T Cells, donor3	11383-118B6	99.48	10.10	17.67	0.76	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	52.07	3.44	1.38	0.23	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	48.17	2.64	1.20	0.00	1.20
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	53.08	1.64	1.64	0.00	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	63.04	6.00	2.70	0.00	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	56.64	3.36	1.92	0.00	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	59.12	3.64	2.05	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	61.06	3.69	2.17	0.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	52.38	3.68	1.84	0.53	1.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	65.90	5.63	2.58	0.47	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	64.30	1.81	1.51	0.30	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	56.36	3.20	2.61	0.29	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	75.40	3.46	0.53	0.00	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	135.70	5.25	4.38	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	152.57	9.11	5.47	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	140.22	4.48	4.48	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	56.54	1.44	2.88	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	53.23	4.60	1.73	0.00	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	45.96	2.83	3.06	0.47	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	67.82	5.39	2.85	0.00	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	66.43	3.38	2.15	0.00	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	68.60	5.45	1.28	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	57.75	4.59	1.53	0.38	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	63.06	3.55	0.00	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	49.92	2.27	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	146.94	4.82	4.82	0.00	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	172.76	5.60	4.20	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	211.37	8.01	2.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	43.87	12.79	9.14	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	34.09	4.94	4.45	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	21.05	4.31	1.26	1.68	0.11
Chondrocyte - de diff, donor1	11261-116G1	26.35	7.28	3.81	3.47	0.00
Chondrocyte - de diff, donor2	11338-117F6	23.81	6.40	0.71	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	31.18	5.35	2.28	2.96	1.14
Chondrocyte - re diff, donor2	11339-117F7	59.98	22.38	4.48	5.37	0.00
Chondrocyte - re diff, donor3	11411-118E7	50.15	7.68	2.43	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	77.46	18.25	4.82	4.93	1.49
Ciliary Epithelial Cells, donor2	11323-117D9	62.42	10.26	5.77	1.71	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	69.56	8.94	4.96	2.48	0.80
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	58.32	12.75	3.48	1.74	0.55
Corneal Epithelial Cells, donor1	11526-119I5	20.86	3.51	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	30.72	7.96	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	55.98	7.16	0.00	0.00	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	33.51	7.59	0.66	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	28.70	6.62	0.95	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	65.56	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	31.86	3.78	0.86	0.22	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	32.11	10.25	2.73	1.71	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	50.92	8.49	1.96	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	45.97	11.13	3.39	1.94	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	40.02	5.00	0.67	0.50	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	36.38	4.69	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	37.33	7.92	0.28	1.41	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	50.72	8.65	0.00	1.97	0.00
Endothelial Cells - Artery, donor1	11264-116G4	33.45	5.53	0.58	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	45.88	6.82	0.24	0.71	0.00
Endothelial Cells - Artery, donor3	11413-118E9	46.11	4.03	0.53	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	38.57	8.87	0.22	0.66	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	44.12	6.69	0.61	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	36.08	5.92	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	35.66	6.54	0.30	0.30	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	27.60	3.12	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	31.48	3.83	0.00	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	54.02	5.60	0.00	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	35.12	4.19	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	78.52	11.43	1.74	1.12	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	109.28	8.26	3.04	0.22	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	109.67	9.28	2.32	1.10	0.24
Endothelial Cells - Vein, donor1	11267-116G7	35.26	3.41	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	29.34	8.38	2.10	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	47.42	5.50	0.79	0.31	0.47
Eosinophils, donor1	12244-129H3	45.74	30.49	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	448.87	99.02	26.40	13.20	0.00
Eosinophils, donor3	12246-129H5	424.45	82.04	21.40	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	25.41	4.40	0.73	0.24	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	18.72	6.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	48.85	6.16	3.28	2.87	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	13.25	1.31	0.11	0.33	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	20.91	3.03	0.43	1.19	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	29.35	5.94	1.09	0.73	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	55.95	10.51	1.50	1.50	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	33.43	4.32	0.74	1.58	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	73.78	7.90	1.84	2.90	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	45.51	7.97	1.99	1.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	38.10	7.71	0.91	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	40.93	3.79	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	29.97	4.73	0.95	1.42	0.63
Fibroblast - Cardiac, donor4	11452-119A3	47.59	8.18	3.94	2.42	0.00
Fibroblast - Cardiac, donor5	11456-119A7	51.52	5.08	1.40	1.40	0.63
Fibroblast - Cardiac, donor6	11460-119B2	47.30	5.00	2.88	1.36	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	35.37	12.19	4.15	2.14	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	41.42	9.49	4.31	0.86	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	41.01	7.32	1.46	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	24.22	7.61	2.54	2.31	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	33.92	8.65	1.02	3.39	0.85
Fibroblast - Dermal, donor1	11269-116G9	35.92	3.52	0.94	0.70	0.23
Fibroblast - Dermal, donor2	11346-117G5	37.26	8.96	0.94	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	30.95	5.68	1.21	0.85	0.97
Fibroblast - Dermal, donor4	11450-119A1	63.53	6.33	2.26	1.47	0.45
Fibroblast - Dermal, donor5	11454-119A5	57.92	8.37	2.62	1.40	0.87
Fibroblast - Dermal, donor6	11458-119A9	63.67	8.61	2.44	0.97	0.49
Fibroblast - Gingival, donor1	11237-116D4	36.86	7.08	1.04	0.00	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	49.26	8.91	0.52	2.36	0.26
Fibroblast - Gingival, donor2	11318-117D4	52.19	8.30	1.45	1.19	0.53
Fibroblast - Gingival, donor3	11394-118C8	48.73	8.41	1.45	3.77	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	41.56	7.27	0.00	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	45.28	5.46	1.59	3.17	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	68.75	9.98	2.34	2.49	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	42.19	5.41	3.11	1.89	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	33.17	3.18	0.35	1.41	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	51.33	5.70	1.61	1.32	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	52.36	7.91	1.50	1.91	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	72.51	7.24	3.73	2.85	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	46.08	6.75	1.03	2.93	0.15
Fibroblast - Lung, donor1	11270-116H1	42.14	5.44	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	46.26	5.97	0.00	1.49	4.48
Fibroblast - Lung, donor3	11419-118F6	45.37	9.07	1.69	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	22.49	10.00	0.00	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	29.37	2.80	1.40	2.80	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	9.52	2.52	0.28	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	55.62	10.56	4.06	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	19.97	7.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	42.48	10.28	1.16	1.55	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	87.67	12.44	3.03	1.82	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	33.05	10.10	1.22	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	46.94	6.49	3.82	3.82	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	40.77	2.43	4.05	2.70	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	46.04	6.03	2.20	3.36	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	25.09	4.75	1.99	0.77	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	40.03	9.96	3.86	1.02	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	27.40	5.35	2.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	29.26	1.98	1.19	0.40	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	94.66	16.67	10.32	5.36	2.58
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	24.33	4.44	1.95	2.49	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	21.48	6.70	2.56	1.77	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	76.42	12.64	6.62	4.21	1.50
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	48.25	8.10	2.27	1.62	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	81.49	12.65	6.83	4.30	0.25
Fibroblast - skin normal, donor1	11553-120C5	23.63	5.41	1.97	2.95	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	104.87	16.24	7.22	3.61	1.20
Fibroblast - skin normal, donor2	11561-120D4	42.40	6.53	7.74	5.32	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	119.38	16.93	9.07	5.74	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	30.90	7.21	1.99	2.07	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	57.61	12.65	1.71	3.25	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	70.61	14.45	5.91	2.63	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	45.70	7.88	3.83	2.77	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	28.68	6.75	3.54	2.02	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	23.37	3.92	1.73	1.41	1.25
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	0.00	22.16	0.00	66.48
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	79.31	7.84	0.00	0.00	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	36.06	4.85	1.04	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	42.42	4.94	0.52	0.26	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	57.75	5.62	0.51	1.28	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	89.57	16.08	1.53	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	76.57	15.31	3.19	0.64	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	117.24	17.12	2.85	1.14	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	163.25	46.60	1.65	1.65	3.58
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	157.55	30.60	3.88	5.71	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	118.28	21.00	1.98	0.59	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	151.20	32.51	1.85	1.85	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	130.13	24.13	3.26	4.24	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	103.92	13.71	3.98	4.86	6.19
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	94.40	20.49	3.96	1.27	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	114.15	21.80	5.05	3.45	2.22
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	75.48	17.46	1.07	2.69	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	88.21	15.12	2.73	0.99	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	97.73	18.55	3.74	0.97	1.94
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	72.17	13.62	3.86	1.42	2.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	89.90	18.94	4.56	1.83	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	96.54	17.94	8.60	4.48	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	113.00	23.82	5.25	2.19	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	93.67	21.57	4.43	3.84	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	115.56	22.41	6.20	2.23	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	100.09	20.11	4.92	2.68	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	92.15	21.37	5.04	1.81	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	111.45	19.17	5.43	2.54	2.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	81.22	22.70	5.41	3.37	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	95.42	28.93	7.60	4.37	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	75.14	30.91	9.22	1.71	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	104.24	16.71	5.64	1.66	1.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	70.05	22.55	3.58	2.08	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	68.81	21.44	3.27	1.63	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	95.93	23.52	4.75	3.30	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	103.76	23.98	8.19	2.42	1.73
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	89.55	16.34	2.50	1.83	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	82.88	19.18	7.05	3.53	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	124.22	25.71	12.18	3.81	1.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	94.66	20.75	3.40	2.11	1.62
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	105.84	28.22	7.38	3.85	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	100.53	18.10	8.43	2.65	2.08
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	73.24	15.50	4.90	1.90	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	115.55	17.94	6.99	3.04	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	98.16	19.03	7.21	1.46	1.67
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	76.19	19.54	6.15	1.10	2.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	98.19	22.72	7.57	3.37	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	128.60	19.54	6.48	2.69	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	76.74	12.03	4.01	1.34	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	81.70	13.46	3.52	2.30	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	70.60	12.44	3.63	1.17	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	87.83	13.55	3.52	1.36	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	94.39	14.75	5.71	3.32	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	96.50	18.20	5.70	3.07	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	145.79	30.74	8.93	4.96	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	67.41	10.03	5.94	3.03	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	73.04	10.49	6.86	3.83	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	140.80	30.50	6.61	6.61	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	110.88	30.46	2.59	0.80	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	104.77	24.81	3.08	0.92	2.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	122.14	25.98	1.02	1.02	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	67.59	17.52	0.31	0.94	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	52.84	13.85	0.57	0.00	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	96.85	22.14	1.38	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	91.57	14.85	2.47	0.00	9.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	102.50	18.95	2.71	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	91.45	8.02	3.21	4.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	116.50	17.39	3.48	3.48	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	87.55	18.88	2.60	1.30	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	91.42	22.65	2.47	0.82	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	113.30	13.33	6.66	3.33	13.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	83.06	13.98	2.52	1.40	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	64.39	14.05	1.63	1.31	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	102.34	32.71	0.84	1.68	11.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	79.84	20.36	1.59	0.32	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	81.18	18.68	2.38	1.02	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	58.47	25.06	0.00	0.00	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	96.21	33.79	1.15	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	66.89	21.31	1.18	0.30	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	72.85	18.64	0.00	1.69	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	83.26	18.64	1.66	2.90	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	82.85	14.96	2.30	2.76	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	94.83	26.34	0.00	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	79.19	19.99	2.31	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	61.93	11.08	1.96	0.98	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	50.83	7.36	3.34	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	102.10	30.82	3.08	2.31	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	86.61	25.33	3.08	0.34	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	32.30	2.48	0.00	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	85.40	25.48	3.30	2.83	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	68.80	18.71	1.81	0.60	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	90.54	25.43	4.07	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	98.51	29.12	2.39	1.20	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	71.54	23.68	1.48	0.99	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	107.42	27.15	2.36	4.72	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	77.01	19.25	4.08	1.17	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	75.49	23.70	2.63	4.39	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	48.32	19.50	2.54	2.54	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	63.27	18.50	0.60	2.39	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	62.60	11.65	1.46	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	29.67	1.14	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	36.59	6.65	0.00	2.08	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	24.74	3.37	1.12	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.96	3.81	0.32	0.63	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	20.05	3.34	0.42	0.84	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	36.09	5.45	2.67	2.55	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	38.32	5.57	2.36	3.21	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	39.59	5.23	2.28	2.73	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	37.49	5.68	2.08	2.08	1.20
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	39.54	6.23	3.22	5.16	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	35.09	5.81	0.86	1.08	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	29.64	4.61	3.11	1.49	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	31.39	4.12	1.89	2.74	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	27.23	3.20	0.32	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	47.01	7.83	2.80	1.68	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	28.56	4.33	2.60	0.43	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	23.79	7.93	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	29.63	8.11	3.17	3.53	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	26.88	6.54	3.63	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	36.89	3.32	2.10	1.57	0.52
Hepatocyte, donor1	11523-119I2	42.37	4.84	0.00	1.21	2.42
Hepatocyte, donor2	11603-120I1	51.71	7.54	0.00	2.15	1.08
Hepatocyte, donor3	11684-122I1	47.24	4.91	1.23	2.45	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	101.17	18.28	14.36	0.00	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	78.30	10.31	0.17	2.97	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	22.64	5.49	1.37	0.41	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	105.07	12.74	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	20.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	54.17	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	102.44	26.30	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	32.53	2.50	7.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	23.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	97.39	7.69	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	63.99	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	118.58	24.36	1.62	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	73.36	13.34	1.67	1.67	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	50.83	10.89	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	125.73	15.88	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	97.56	13.30	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	20.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	98.89	16.38	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	94.34	18.56	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	87.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	121.46	15.50	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	135.23	17.71	6.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	35.84	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	147.49	13.04	0.81	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	91.10	21.41	1.26	0.42	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	43.12	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	106.09	12.06	2.41	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	98.79	9.23	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	30.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	93.46	12.75	1.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	101.58	12.70	2.72	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	132.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	128.06	18.29	0.00	1.08	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	146.10	16.52	2.54	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	131.44	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	117.97	20.41	2.55	0.00	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	107.54	18.23	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	131.39	17.14	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	136.05	13.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	104.24	41.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	87.66	13.89	0.93	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	119.41	21.07	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	72.29	15.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	110.57	12.52	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	55.33	11.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	22.69	0.00	3.24	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	72.37	18.31	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	56.24	24.75	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	45.30	31.36	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	54.41	17.07	0.00	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	58.19	22.17	2.77	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	82.64	14.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	65.35	18.41	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	15.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	12.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	38.07	12.69	1.06	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	34.35	4.57	0.57	0.57	0.33
Keratinocyte - epidermal, donor2	11349-117G8	12.30	1.17	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	39.66	3.98	0.57	0.38	0.28
Keratinocyte - oral, donor1	11251-116E9	70.95	11.12	0.79	1.14	1.14
Keratocytes, donor1	11527-119I6	23.04	10.31	0.69	2.41	0.00
Keratocytes, donor2	11607-120I5	42.18	5.86	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	41.69	9.88	1.98	1.58	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	175.83	15.39	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	36.68	2.16	2.16	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	47.63	10.50	1.96	3.11	0.35
Lens Epithelial Cells, donor3	11690-122I7	50.56	10.09	1.41	1.82	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	33.68	2.49	0.59	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	24.00	1.95	0.00	0.00	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	41.87	2.52	1.26	0.00	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	29.57	1.61	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	38.77	2.84	0.63	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	32.13	3.77	0.75	0.11	1.62
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	27.09	2.05	1.23	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	25.53	1.77	0.00	0.00	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	35.47	2.67	0.56	0.00	1.83
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	30.85	3.96	1.58	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	29.66	1.74	0.39	0.19	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	23.33	1.48	0.19	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	37.63	4.18	0.35	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	26.24	2.62	0.72	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	30.63	2.61	0.14	0.14	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	28.64	1.85	0.00	0.00	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	23.69	1.25	0.31	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	39.16	2.74	0.37	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	39.49	2.30	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	19.92	1.76	0.29	0.00	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	30.62	2.74	1.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	29.10	3.88	0.00	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	30.16	2.15	0.81	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	41.48	2.27	0.30	0.00	1.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	30.59	2.59	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	31.20	2.30	0.21	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	35.64	3.61	0.60	0.15	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	24.08	5.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	24.65	2.26	0.38	0.19	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	38.28	2.65	0.32	0.21	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	31.01	2.91	0.97	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	23.16	1.65	0.66	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	35.31	3.59	0.12	0.37	1.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	42.20	5.18	0.74	0.74	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	19.03	1.73	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	31.21	3.85	0.41	0.27	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	29.59	3.22	0.00	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	25.87	3.04	0.61	0.00	1.22
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	39.19	3.92	0.42	0.42	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	31.64	3.20	0.71	0.00	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	12.12	1.45	0.97	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	23.96	3.58	0.62	0.31	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	28.29	2.15	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	32.34	2.61	0.98	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	25.90	2.12	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	37.25	5.32	0.62	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	23.82	2.31	0.77	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	32.82	4.18	0.30	0.30	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	45.32	13.60	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	67.51	4.60	0.00	1.53	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	39.34	5.20	0.00	1.48	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	55.01	3.39	1.27	0.42	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	65.41	2.81	0.00	0.70	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	39.23	2.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	42.25	1.03	0.00	0.52	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	48.77	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	46.82	3.85	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	67.18	7.56	0.87	0.29	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	67.53	2.70	1.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	62.87	7.18	0.27	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	61.62	5.14	0.00	1.03	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	59.99	6.70	0.35	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	39.98	2.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	63.67	5.09	0.00	1.02	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	65.63	4.00	0.27	0.80	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	89.56	6.05	0.57	0.76	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	59.52	5.52	0.00	0.61	3.07
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	76.65	6.52	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	85.59	5.00	0.00	0.42	2.71
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	62.78	7.57	0.56	0.84	2.52
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	62.85	9.27	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	88.83	6.68	1.16	0.00	3.48
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	53.51	4.48	0.60	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	61.96	5.53	1.11	0.55	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	78.83	5.66	0.35	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	58.27	4.79	1.11	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	43.75	4.61	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	67.54	3.84	0.77	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	45.29	5.66	0.57	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	50.87	4.92	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	70.49	4.97	0.45	0.00	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	49.55	4.31	1.44	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	65.73	5.23	2.24	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	83.61	5.57	1.11	0.37	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	46.52	5.17	0.43	0.43	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	74.50	4.28	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	75.96	5.33	0.33	0.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	49.47	14.48	0.60	0.60	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	56.88	4.98	0.00	1.42	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	66.68	5.84	0.34	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	59.58	3.76	1.07	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	69.36	7.41	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	70.75	3.33	0.00	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	47.68	10.47	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	56.06	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	80.03	7.20	2.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	48.70	7.27	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	71.29	4.60	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	68.57	5.92	0.99	1.48	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	61.16	2.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	71.90	3.52	0.50	0.00	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	69.85	4.06	1.35	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	6.88	0.00	0.00	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	66.36	5.79	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	71.56	4.30	0.78	0.00	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	48.82	5.94	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	69.02	7.26	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	81.82	5.69	0.44	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	36.34	7.27	0.00	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	56.09	6.62	0.44	0.00	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	75.60	7.33	0.77	0.39	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	46.58	3.04	0.51	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	54.79	5.77	0.48	0.96	2.88
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	82.69	5.96	0.40	0.40	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	54.08	5.47	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	61.56	3.46	0.00	0.00	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	78.28	3.42	0.00	0.76	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	50.09	3.61	0.52	0.52	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	58.05	4.23	1.21	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	79.86	5.39	0.95	0.00	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	53.31	5.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	71.26	4.60	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	80.73	3.09	0.51	0.51	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	57.30	4.24	0.00	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	67.53	5.67	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	72.39	4.16	1.25	0.42	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	49.33	4.70	0.78	0.78	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	65.55	4.59	0.00	0.84	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	71.55	4.65	0.00	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	47.50	4.01	0.67	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	83.94	3.21	0.00	0.53	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	75.97	5.66	0.00	0.00	1.62
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	42.22	3.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	55.12	6.22	0.89	0.00	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	87.19	6.27	0.57	0.00	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	55.22	3.83	0.77	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	84.27	2.74	0.55	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	76.17	4.90	0.89	0.89	2.23
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	71.23	4.68	0.52	0.00	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	72.94	5.30	0.00	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	101.85	6.24	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	35.55	6.38	1.60	0.91	0.00
Macrophage - monocyte derived, donor2	11313-117C8	29.54	4.95	2.94	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	53.22	4.98	2.62	1.31	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	19.12	1.59	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	27.41	4.75	0.95	1.11	0.32
Mallassez-derived cells, donor3	11930-125I4	33.50	4.45	0.14	0.14	0.42
Mammary Epithelial Cell, donor1	11273-116H4	34.28	6.38	0.30	1.59	0.70
Mammary Epithelial Cell, donor2	11350-117G9	32.14	4.34	0.29	1.16	0.58
Mammary Epithelial Cell, donor3	11422-118F9	26.69	2.00	0.25	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	189.82	16.95	235.24	2.03	0.68
Mast cell, donor1	11563-120D6	75.16	15.79	15.36	2.60	0.43
Mast cell, donor2	11565-120D8	176.82	26.45	23.18	7.43	0.30
Mast cell, donor3	11566-120D9	145.21	24.09	17.11	11.48	0.23
Mast cell, donor4	11567-120E1	185.80	26.77	15.60	12.59	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	44.80	9.65	13.75	2.44	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	48.45	14.01	62.45	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	42.10	10.78	5.16	2.64	0.11
Mast cell, expanded, donor8	11941-126A6	75.65	14.23	6.53	1.51	0.17
Melanocyte - dark, donor1	11502-119F8	28.66	4.28	0.10	0.30	0.10
Melanocyte - dark, donor2	11582-120F7	44.64	4.50	3.81	1.73	0.35
Melanocyte - dark, donor3	11663-122F7	51.94	11.08	2.68	1.09	0.43
Melanocyte - light, donor1	11274-116H5	28.91	6.58	3.53	2.12	0.47
Melanocyte - light, donor2	11351-117H1	36.85	5.46	2.05	0.68	0.00
Melanocyte - light, donor3	11423-118G1	26.88	5.20	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	48.42	5.21	2.19	1.15	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	57.02	8.61	1.88	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	40.98	7.77	1.61	2.14	0.54
Meningeal Cells, donor1	11493-119E8	44.79	14.02	10.30	2.98	0.12
Meningeal Cells, donor2	11573-120E7	44.01	12.32	14.97	9.24	1.32
Meningeal Cells, donor3	11654-122E7	32.44	6.93	8.72	1.96	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	55.04	10.55	3.71	2.00	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	35.32	4.93	0.50	0.60	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	1.31	1.31	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	13.08	2.62	2.62	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	45.93	3.59	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	32.61	5.93	1.48	3.39	0.85
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	35.19	3.52	3.02	1.51	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	36.04	11.21	1.98	3.52	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	61.37	8.04	5.11	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	43.38	7.37	2.66	0.61	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	30.06	5.54	0.97	1.80	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	19.70	5.95	1.12	0.74	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	30.00	6.18	1.97	1.71	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	28.19	7.72	1.19	3.26	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	28.03	2.34	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	54.43	10.25	1.92	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	34.03	7.44	0.35	1.06	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	32.21	6.25	1.56	1.25	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	33.38	7.98	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	27.05	5.30	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	26.52	3.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	28.98	3.25	0.87	0.94	0.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	194.45	21.61	10.80	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	60.58	8.87	4.68	1.23	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	51.82	6.77	3.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	134.83	0.00	10.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	46.49	4.03	2.79	0.62	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	38.17	4.98	3.53	0.00	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	120.43	18.53	4.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	59.81	8.26	3.25	1.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	56.79	3.26	6.05	1.40	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	136.26	19.47	58.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	51.82	5.08	3.66	0.41	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	41.18	3.96	3.96	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	179.58	25.65	25.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	19.47	4.42	1.77	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	39.13	2.66	2.66	1.14	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	103.96	11.84	6.58	1.32	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	35.87	2.76	2.97	1.06	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	51.57	3.68	4.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	43.52	1.79	2.09	1.19	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	97.25	13.41	3.35	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	35.13	2.01	1.51	1.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	37.08	6.18	4.75	0.00	1.43
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	80.72	9.40	2.76	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	31.08	2.99	1.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	45.01	4.63	3.16	0.21	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	30.78	2.04	2.24	0.41	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	24.67	3.86	1.72	0.64	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	53.79	4.22	2.67	0.67	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	82.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	28.03	3.29	1.10	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	57.29	3.04	3.04	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	89.48	4.97	1.66	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	33.70	3.81	2.45	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	40.58	2.65	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	47.97	3.27	1.09	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	18.26	0.96	0.96	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	34.82	3.20	3.20	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	47.99	2.74	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	13.52	2.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	53.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	11.39	0.88	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	58.49	5.52	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	36.50	1.92	3.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	19.09	2.23	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	34.10	2.78	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	90.60	8.84	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	28.38	1.03	0.00	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	45.95	2.63	1.31	0.88	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	105.11	2.49	0.36	0.71	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	32.26	1.68	1.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	42.81	4.57	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	114.22	7.58	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	42.53	3.62	0.60	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	50.92	4.59	1.25	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	101.06	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	61.88	2.77	0.00	0.00	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	56.91	2.28	1.71	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	72.27	1.93	0.28	0.28	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	33.17	2.07	0.26	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	75.07	5.58	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	88.93	3.81	1.27	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	41.10	2.94	0.27	0.00	1.33
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	81.42	7.18	2.39	0.30	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	59.61	2.97	0.57	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	31.21	1.59	0.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	65.45	2.87	0.88	0.66	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	77.74	5.69	0.00	0.76	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	38.64	2.27	0.28	0.00	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	54.57	3.44	0.25	0.25	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	108.18	5.87	1.30	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	63.80	3.82	0.88	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	91.98	4.90	2.31	0.58	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	75.42	8.24	1.65	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	65.51	9.23	1.19	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	28.52	5.35	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	43.70	4.27	0.33	0.66	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	3.16	1.05	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	31.83	4.74	0.40	0.79	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	53.09	11.18	2.79	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	33.05	4.13	1.13	1.13	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	35.69	3.73	1.33	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	27.71	4.07	0.34	0.34	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.79	2.95	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	38.11	4.03	0.37	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	46.67	6.22	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	9.09	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	43.43	3.03	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	15.60	1.26	0.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	43.58	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.90	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	49.84	1.51	4.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	576.73	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	378.44	13.05	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	95.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	727.85	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.45	6.46	2.37	3.02	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	48.60	8.88	6.27	4.70	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	41.38	2.00	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	49.25	2.50	1.67	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	150.59	13.88	3.42	1.14	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	172.35	35.11	4.79	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	25.16	2.72	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	242.57	12.86	7.35	1.84	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	32.23	4.19	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	52.53	2.79	2.09	0.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	52.42	5.94	1.35	1.08	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	65.17	9.04	3.15	0.84	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	489.93	22.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	44.18	2.48	0.00	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	52.51	4.33	0.54	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	36.72	2.95	0.45	0.91	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	42.30	5.39	1.14	0.65	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	58.50	7.47	1.09	0.91	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	31.30	5.30	0.00	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	48.02	4.20	1.80	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	129.96	9.85	2.30	0.98	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	42.28	3.42	0.98	0.98	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	88.54	9.70	2.65	2.47	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	28.13	4.22	0.70	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	51.03	4.14	0.46	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	49.49	2.89	1.93	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	130.71	7.93	1.72	1.38	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	447.53	40.46	5.06	5.06	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	80.20	8.91	2.67	2.67	1.11
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	38.11	2.96	1.27	2.96	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	69.31	3.80	0.95	0.95	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	47.22	3.86	1.29	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	487.50	18.06	18.06	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	65.98	6.00	1.33	1.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	56.81	7.21	2.25	2.25	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	30.55	3.97	0.79	1.98	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	50.15	2.79	0.93	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	57.13	6.05	1.89	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	39.43	4.24	0.65	1.30	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	67.55	3.92	0.44	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	85.48	12.21	4.52	2.71	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	27.34	3.53	2.65	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	46.54	1.33	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	69.94	3.97	1.49	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	47.85	3.06	1.15	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	78.33	7.56	1.51	0.60	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	58.57	3.98	1.99	1.55	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	48.11	1.36	0.68	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	286.13	30.66	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	44.51	4.88	1.83	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	62.32	4.41	0.94	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	63.56	4.84	0.61	0.61	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	31.65	1.58	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	175.71	11.34	6.80	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	278.18	20.23	5.06	5.06	5.06
Myoblast, donor1	11241-116D8	28.45	3.98	1.61	0.62	0.25
Myoblast, donor2	11322-117D8	58.69	8.63	2.11	1.92	1.73
Myoblast, donor3	11398-118D3	35.82	7.40	2.69	2.19	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	79.53	11.67	0.73	1.31	1.75
Natural Killer Cells, donor1	11230-116C6	68.27	19.37	19.07	3.69	0.31
Natural Killer Cells, donor2	11311-117C6	118.81	12.06	14.17	2.11	1.21
Natural Killer Cells, donor3	11387-118C1	101.60	13.07	16.01	2.21	1.84
Neural stem cells, donor1	11275-116H6	80.94	43.55	2.54	1.45	0.36
Neural stem cells, donor2	11352-117H2	63.55	51.99	1.93	0.00	0.00
Neurons, donor1	11494-119E9	56.89	25.03	2.28	0.00	1.14
Neurons, donor2	11574-120E8	34.79	17.83	1.10	1.10	0.22
Neurons, donor3	11655-122E8	67.42	15.62	1.64	0.00	1.64
Neutrophils, donor1	11233-116C9	305.31	62.18	12.99	0.00	5.57
Neutrophils, donor2	11314-117C9	237.71	57.98	14.49	5.80	5.80
Neutrophils, donor3	11390-118C4	436.75	105.68	20.77	2.44	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	48.92	13.18	3.32	5.34	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	46.56	4.23	2.60	5.86	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	37.10	6.22	1.80	2.21	0.60
Olfactory epithelial cells, donor1	11933-125I7	32.76	4.13	0.96	1.24	0.83
Olfactory epithelial cells, donor2	11934-125I8	36.62	4.20	1.16	2.03	0.72
Olfactory epithelial cells, donor3	11935-125I9	30.76	4.54	0.91	0.79	0.11
Olfactory epithelial cells, donor4	11936-126A1	48.02	4.68	0.68	1.56	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	60.18	7.82	0.60	2.41	1.20
Osteoblast - differentiated, donor1	11276-116H7	40.41	10.00	1.49	2.13	0.21
Osteoblast - differentiated, donor2	11353-117H3	34.29	3.43	0.00	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	24.21	3.72	1.86	2.48	0.00
Osteoblast, donor1	11277-116H8	34.79	7.82	1.95	1.37	0.20
Osteoblast, donor2	11354-117H4	47.76	10.53	8.43	0.70	1.40
Osteoblast, donor3	11426-118G4	56.52	6.93	3.20	0.71	0.89
Pancreatic stromal cells, donor1	11249-116E7	43.30	5.22	0.93	0.76	0.59
Pericytes, donor1	11491-119E6	19.14	6.23	6.68	4.78	0.45
Pericytes, donor2	11571-120E5	26.03	6.34	4.75	4.75	0.45
Pericytes, donor3	11652-122E5	25.43	4.88	1.22	1.02	0.20
Perineurial Cells, donor1	11499-119F5	29.16	6.89	2.26	1.24	0.34
Perineurial Cells, donor2	11579-120F4	48.58	7.82	2.67	1.38	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	37.93	20.72	7.65	1.59	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	70.03	12.49	10.04	0.49	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	50.73	11.00	8.28	2.85	0.39
Placental Epithelial Cells, donor1	11278-116H9	25.35	6.70	0.24	0.24	0.24
Placental Epithelial Cells, donor2	11355-117H5	22.18	6.65	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	35.34	4.12	0.98	0.79	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	9.81	1.58	0.63	1.58	0.00
Preadipocyte - breast, donor1	11467-119B9	17.82	4.50	1.88	2.25	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	70.88	13.97	7.31	5.61	0.52
Preadipocyte - breast, donor2	11328-117E5	26.57	3.60	3.60	3.60	0.00
Preadipocyte - omental, donor1	11468-119C1	20.46	5.11	1.92	3.73	0.64
Preadipocyte - omental, donor2	11329-117E6	26.19	3.49	5.24	3.06	0.44
Preadipocyte - omental, donor3	11403-118D8	29.65	5.01	1.15	2.01	0.29
Preadipocyte - perirenal, donor1	11469-119C2	15.75	2.95	0.98	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	21.50	3.07	1.54	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	63.22	6.91	2.48	0.71	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	35.93	4.94	1.36	0.85	0.51
Preadipocyte - visceral, donor1	11280-116I2	40.89	9.31	1.02	0.93	0.37
Preadipocyte - visceral, donor2	11357-117H7	35.89	4.14	1.38	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	50.36	4.60	2.19	0.84	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	61.55	12.22	0.91	3.62	1.51
Prostate Epithelial Cells, donor2	11331-117E8	31.55	1.90	0.54	0.27	0.14
Prostate Epithelial Cells, donor3	11404-118D9	18.13	5.02	0.31	0.67	0.37
Prostate Stromal Cells, donor1	11254-116F3	31.66	5.58	2.16	2.16	0.34
Prostate Stromal Cells, donor2	11332-117E9	43.21	4.66	1.43	1.79	0.90
Prostate Stromal Cells, donor3	11405-118E1	33.16	4.38	0.63	2.09	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	32.48	9.49	1.46	1.46	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	29.87	7.69	2.01	0.76	0.49
Renal Epithelial Cells, donor1	11517-119H5	30.43	6.59	1.52	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	49.08	7.11	1.42	0.71	2.85
Renal Epithelial Cells, donor3	11678-122H4	37.69	7.73	2.12	0.64	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	33.36	5.45	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	38.41	4.72	0.81	0.81	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	75.26	7.99	2.00	0.00	2.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	20.63	5.32	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	44.68	8.58	4.40	1.32	0.22
Renal Mesangial Cells, donor2	11598-120H5	67.09	15.05	5.64	4.39	1.88
Renal Mesangial Cells, donor3	11679-122H5	35.51	2.77	0.83	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	35.16	9.13	1.34	1.88	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	33.31	3.37	2.11	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	55.93	7.52	3.66	1.16	0.77
Retinal Pigment Epithelial Cells, donor0	11215-116A9	42.26	8.56	0.52	1.81	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	59.98	13.64	1.14	1.71	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	29.84	5.15	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	23.59	8.78	1.51	4.27	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	42.36	7.22	1.74	2.41	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	132.22	28.59	0.89	4.47	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	105.67	17.61	1.65	2.20	10.46
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	248.84	41.18	6.38	3.48	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	132.50	31.86	4.94	5.46	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	133.67	18.27	3.38	4.77	1.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	90.68	26.88	3.46	5.02	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	152.82	29.89	5.09	6.70	4.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	140.09	24.47	4.20	4.31	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	173.81	30.28	5.08	5.78	3.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	103.91	20.54	3.56	5.34	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	152.03	23.45	4.99	4.84	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	104.29	29.21	5.38	3.58	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	91.09	19.65	4.16	3.73	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	119.33	20.93	3.86	3.86	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	140.95	20.58	3.76	3.76	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	92.72	21.03	3.82	4.01	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	136.58	25.25	4.10	4.66	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	98.65	25.93	3.01	3.19	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	132.18	22.56	6.64	6.10	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	156.82	26.09	5.55	5.55	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	131.76	21.77	4.96	3.44	2.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	108.18	21.04	4.49	5.55	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	130.62	26.63	5.89	5.61	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	156.37	26.15	4.96	3.42	3.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	112.86	20.06	6.20	5.47	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	121.90	19.87	3.80	5.03	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	139.29	22.16	3.76	3.90	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	72.41	17.69	5.19	3.07	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	123.81	18.06	3.37	2.58	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	132.36	26.66	5.38	4.44	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	75.68	16.59	3.53	4.15	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	107.07	22.56	4.20	4.42	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	134.52	26.32	5.85	4.18	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	91.25	20.73	5.38	5.11	2.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	165.53	30.99	9.03	4.60	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	156.93	25.64	7.33	4.43	3.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	89.92	20.98	5.67	4.64	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	144.44	28.53	7.00	5.76	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	170.74	27.74	6.07	4.43	3.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	104.30	22.33	4.77	6.65	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	148.11	25.30	6.07	4.88	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	173.79	22.12	7.46	3.73	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	116.70	15.90	2.35	6.08	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	103.10	20.71	2.86	3.81	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	191.67	27.21	2.42	3.63	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	93.61	19.02	2.07	2.83	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	148.83	21.31	5.94	3.49	3.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	138.72	19.64	3.02	3.02	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	92.28	18.24	1.96	1.59	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	122.85	29.55	5.24	6.55	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	167.93	20.69	5.48	4.26	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	81.08	14.47	3.01	3.32	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	142.27	22.17	4.07	6.11	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	149.17	23.36	3.89	5.99	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	120.91	23.97	3.66	2.72	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	166.27	23.91	4.48	4.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	192.31	22.24	7.81	2.40	0.00
Schwann Cells, donor1	11498-119F4	42.88	7.71	3.20	1.69	0.75
Schwann Cells, donor2	11578-120F3	10.21	3.40	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	44.25	5.48	5.04	1.53	0.66
Sebocyte, donor1	11220-116B5	71.76	4.93	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	58.36	3.22	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	32.15	3.30	1.03	0.41	0.21
Sertoli Cells, donor1	11255-116F4	43.07	8.28	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	22.59	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	25.43	7.39	2.20	2.38	0.44
Skeletal Muscle Cells, donor2	11358-117H8	21.69	5.06	5.78	4.34	0.00
Skeletal Muscle Cells, donor3	11430-118G8	57.69	7.52	1.67	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	52.16	7.54	4.56	2.36	0.16
Skeletal Muscle Cells, donor5	11455-119A6	62.28	6.24	5.95	4.01	0.45
Skeletal Muscle Cells, donor6	11459-119B1	76.34	6.62	3.39	1.69	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	65.40	15.25	3.28	5.42	1.26
Skeletal Muscle Satellite Cells, donor2	11321-117D7	69.63	10.84	3.85	6.99	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	71.93	10.62	6.15	2.28	1.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	36.48	8.85	6.99	3.79	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	26.78	13.75	2.90	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	34.67	5.37	2.06	1.24	0.14
Skin - palm, donor1	10286-104F7	112.82	8.06	10.74	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	38.20	2.88	0.86	0.14	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	123.50	23.72	3.27	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	38.30	2.08	0.00	0.13	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	22.80	4.73	0.42	0.70	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	62.17	4.78	1.13	1.55	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	148.22	16.92	0.00	0.42	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	33.80	3.75	0.37	0.45	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	7.10	1.54	0.62	1.85	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	38.24	8.00	1.33	1.33	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	36.45	4.70	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	70.28	10.17	2.21	0.66	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	15.75	7.48	0.79	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.18	8.50	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	49.04	6.00	2.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	25.42	4.92	0.27	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	39.01	7.09	0.66	0.44	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	48.14	6.15	2.94	0.90	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	28.33	7.16	6.84	3.26	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	37.80	6.79	0.89	2.07	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	41.86	5.69	1.00	1.00	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	11.22	3.58	0.00	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	42.32	4.57	2.13	3.04	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	34.10	9.09	0.76	1.26	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	171.38	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	21.93	3.81	0.95	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	28.61	5.90	0.88	1.92	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	51.23	5.60	0.43	0.65	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	42.82	7.66	1.36	1.68	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	25.06	3.40	0.93	0.62	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	29.10	2.16	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	34.67	2.99	0.60	0.60	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	18.44	5.46	1.02	1.02	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	37.22	8.95	1.41	2.67	0.63
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	39.45	6.54	1.41	0.91	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	32.08	3.87	0.91	0.00	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	21.74	4.83	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	56.96	8.74	2.91	2.38	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	38.62	6.92	2.26	2.26	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	40.20	5.13	1.25	1.88	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	25.87	7.36	2.79	3.04	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	33.32	8.44	1.21	1.21	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	29.26	4.50	1.50	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	841.23	58.15	32.31	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	33.02	9.77	0.00	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	27.26	1.51	0.00	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	28.83	3.13	0.63	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	9.44	5.60	0.00	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	55.73	11.50	1.83	0.92	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	44.85	6.54	0.93	1.40	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	20.00	6.62	0.43	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	38.24	5.10	1.27	0.76	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	29.71	5.45	0.75	0.38	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	40.81	7.55	0.98	0.28	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	29.16	4.02	1.09	0.92	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	10.95	2.86	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	21.77	5.87	0.98	0.73	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	28.50	4.86	1.55	0.66	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	30.43	7.02	0.59	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	42.95	8.94	2.33	2.53	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	25.12	3.70	0.79	1.06	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	34.96	4.46	1.12	0.74	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	42.40	5.03	0.36	2.16	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	27.25	3.97	1.42	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	30.72	6.70	1.97	2.36	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	43.43	4.32	0.51	0.51	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	38.73	8.39	0.40	0.00	2.40
Smooth muscle cells - airway, control, donor3	11968-126D6	36.78	8.36	0.42	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	33.00	2.75	0.00	0.92	0.92
Synoviocyte, donor1	11291-117A4	30.30	5.72	5.05	1.35	0.17
Synoviocyte, donor2	11368-117I9	26.15	3.35	1.17	0.67	0.50
Synoviocyte, donor3	11440-118H9	29.94	3.80	1.56	1.56	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	37.52	8.22	1.07	1.07	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	7.93	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	38.21	5.56	0.46	0.69	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	33.55	4.52	0.65	0.29	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	24.74	1.16	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	18.90	5.73	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	44.29	8.24	1.85	3.08	0.37
Urethra, donor2	10319-105A4	134.88	19.78	1.80	3.60	1.80
Urothelial Cells, donor1	11520-119H8	23.11	5.05	0.00	0.27	1.06
Urothelial Cells, donor2	11600-120H7	37.65	4.41	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	30.03	5.04	0.00	0.23	0.23
Urothelial cells, donor0	11216-116B1	52.16	9.58	0.45	0.67	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	30.25	24.02	5.34	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	20.01	17.16	2.86	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	33.54	13.69	8.21	2.05	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	29.96	13.77	5.85	1.38	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	16.85	18.59	5.23	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	20.82	24.99	3.12	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	13.77	24.78	6.42	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	31.04	13.69	7.30	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	101.28	13.20	0.74	0.86	1.48
Wilms' tumor cell line:HFWT	10597-108E3	52.80	15.84	0.88	2.64	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	64.52	7.54	0.28	0.84	0.84
achilles tendon, donor2	10292-104G4	88.86	10.33	4.13	2.07	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	134.62	15.30	4.33	0.51	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	104.71	16.02	25.31	4.18	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	158.24	24.69	5.70	1.90	2.02
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	85.99	19.32	4.90	0.82	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	94.16	19.11	16.58	2.81	5.06
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	94.32	15.44	3.81	1.90	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	154.62	19.87	5.99	1.63	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	94.30	14.54	0.88	0.00	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	81.67	13.88	1.23	0.00	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	82.71	13.59	7.38	1.94	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	64.03	13.62	3.31	1.84	2.02
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	171.62	54.61	0.00	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	91.33	16.03	3.25	1.16	3.02
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	96.31	22.01	1.81	1.55	2.59
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	85.92	17.83	3.51	0.58	3.80
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	90.16	16.73	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	88.01	17.27	0.82	0.00	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	88.40	5.22	0.61	0.00	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	58.03	5.97	1.28	0.85	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	53.68	6.37	0.61	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	61.86	7.70	0.48	0.24	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	88.43	9.58	1.11	0.89	3.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	232.15	22.01	14.68	3.00	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	252.72	89.19	9.29	20.44	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	105.46	25.24	10.55	3.77	2.26
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	275.20	33.58	20.06	3.49	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	228.68	37.49	18.74	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	47.81	4.95	0.00	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	37.23	8.38	0.31	1.09	0.31
adipose, donor1	10184-103D4	292.03	69.20	6.45	3.52	12.90
adipose, donor2	10185-103D5	96.92	26.76	2.03	2.84	0.81
adipose, donor3	10186-103D6	161.74	28.59	5.17	4.90	1.91
adipose, donor4	10187-103D7	303.36	33.80	14.73	2.60	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	69.91	9.63	2.05	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	36.38	14.55	0.00	7.28	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	67.37	6.94	0.67	0.13	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	35.73	5.36	0.36	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	57.50	5.10	0.46	0.93	0.00
amniotic membrane cells, donor2	12236-129G4	96.02	10.14	1.01	2.37	1.01
amniotic membrane cells, donor3	12237-129G5	50.67	9.72	0.59	1.47	0.88
amygdala - adult, donor10196	10167-103B5	43.87	11.86	0.00	0.00	3.56
amygdala, adult, donor10252	10151-102I7	60.42	10.34	1.01	2.23	0.61
amygdala, newborn, donor10223	10360-105E9	42.93	8.71	15.49	0.97	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	45.84	7.77	0.76	0.38	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	85.60	8.38	0.22	0.44	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	93.86	21.71	7.01	3.34	3.01
aorta, adult, pool1	10052-101G7	59.43	5.88	0.98	1.96	1.18
appendix, adult	10189-103D9	150.20	17.08	8.54	0.78	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	80.82	23.04	0.34	1.72	2.41
artery, adult	10190-103E1	40.76	9.51	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	82.57	32.60	8.98	3.77	0.29
b cell line:RPMI1788	10427-106D4	58.89	8.18	1.19	0.45	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	43.00	5.27	1.94	1.94	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	67.78	11.61	1.49	1.29	0.99
bile duct carcinoma cell line:TFK-1	10496-107C1	36.82	5.02	0.00	0.00	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	68.79	15.10	0.56	2.80	1.12
bladder, adult, pool1	10011-101C2	71.49	11.84	1.20	3.37	0.43
blood, adult, pool1	10053-101G8	28.79	8.86	2.21	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	102.76	19.70	0.86	1.71	0.86
bone marrow, adult	10192-103E3	51.96	6.75	7.42	3.37	2.02
brain, adult, donor1	10084-102B3	36.90	10.25	1.03	1.03	0.00
brain, adult, pool1	10012-101C3	45.88	9.24	1.34	1.78	0.67
brain, fetal, pool1	10085-102B4	42.74	5.34	0.00	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	168.49	18.83	1.98	8.92	2.64
breast carcinoma cell line:MDA-MB-453	10419-106C5	89.12	9.24	0.25	0.62	0.62
breast, adult, donor1	10080-102A8	46.09	6.31	0.00	1.26	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	71.65	4.07	0.51	1.65	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	162.34	17.63	0.31	1.24	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	43.05	7.60	1.84	1.15	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	74.56	8.72	1.69	1.45	0.73
carcinoid cell line:NCI-H1770	10703-109H1	99.68	9.40	0.47	1.41	0.94
carcinoid cell line:NCI-H727	10735-110B6	133.01	18.92	0.98	1.31	1.42
carcinoid cell line:SK-PN-DW	10719-109I8	69.08	14.58	1.58	2.85	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	78.79	20.76	1.06	3.19	1.60
caudate nucleus - adult, donor10196	10177-103C6	73.68	9.21	0.00	4.61	0.00
caudate nucleus, adult, donor10252	10164-103B2	48.86	13.05	2.18	1.34	1.17
caudate nucleus, adult, donor10258	10379-105H1	34.39	19.87	2.29	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	44.31	10.25	8.42	1.46	0.73
cerebellum - adult, donor10196	10173-103C2	87.40	11.65	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	81.56	14.95	1.92	1.49	0.43
cerebellum, adult, pool1	10083-102B2	49.33	7.24	1.03	0.69	2.07
cerebellum, newborn, donor10223	10357-105E6	91.33	9.96	8.30	4.15	3.32
cerebral meninges, adult	10188-103D8	78.92	16.64	1.76	2.27	0.25
cerebrospinal fluid, donor2	10294-104G6	62.86	4.39	2.92	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	25.74	13.80	2.16	5.90	0.29
cervical cancer cell line:ME-180	10553-107I4	55.68	12.93	0.83	4.31	0.66
cervix, adult, pool1	10013-101C4	71.92	15.54	2.62	3.46	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	88.06	7.80	1.39	0.98	0.70
chondrosarcoma cell line:SW 1353	10700-109G7	151.53	19.59	10.45	2.61	1.31
choriocarcinoma cell line:BeWo	10423-106C9	79.91	22.25	0.50	0.62	1.37
choriocarcinoma cell line:SCH	10785-110H2	55.32	5.30	0.12	0.25	1.60
choriocarcinoma cell line:T3M-3	10618-108G6	111.95	14.23	0.24	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	45.87	4.56	0.85	0.57	0.57
chorionic membrane cells, donor2	12239-129G7	75.87	10.04	1.19	1.29	0.50
chorionic membrane cells, donor3	12240-129G8	48.35	6.59	1.10	0.00	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	77.75	13.13	16.16	1.01	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	113.34	14.02	8.84	1.34	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	90.60	17.32	6.55	4.86	0.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	93.73	18.49	4.11	1.54	2.57
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	111.51	27.33	1.45	1.45	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	135.40	26.67	5.50	2.04	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	110.72	37.69	1.47	0.59	1.77
chronic myelogenous leukemia cell line:KU812	10409-106B4	154.81	25.02	4.17	1.30	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	59.66	9.83	0.00	0.23	2.29
clear cell carcinoma cell line:TEN	10636-108I6	63.16	9.54	1.39	1.39	0.52
colon carcinoma cell line:CACO-2	10513-107D9	72.85	8.05	0.55	2.01	0.37
colon carcinoma cell line:COLO-320	10420-106C6	123.91	36.11	0.38	0.38	0.76
colon, adult, donor1	10082-102B1	65.45	15.47	1.19	1.19	1.19
colon, adult, pool1	10014-101C5	64.74	17.63	1.29	2.00	0.24
colon, fetal, donor1	10070-101I7	59.94	9.27	1.85	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	540.86	197.09	13.75	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	50.07	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	107.93	7.65	1.70	0.42	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	68.67	6.49	3.17	0.60	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	77.42	8.04	5.50	0.71	0.71
corpus callosum, adult, pool1	10042-101F6	89.22	18.13	1.44	2.65	0.44
cruciate ligament, donor2	10295-104G7	92.39	10.54	3.24	3.24	0.81
diaphragm, fetal, donor1	10069-101I6	31.30	4.82	0.80	0.80	0.80
diencephalon, adult	10193-103E4	56.64	11.28	1.92	1.92	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	94.37	13.78	0.69	0.46	4.82
ductal cell carcinoma cell line:KLM-1	10438-106E6	91.81	26.67	3.59	5.13	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	42.37	9.15	1.44	1.93	0.00
ductus deferens, adult	10196-103E7	97.67	10.96	1.00	1.99	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	47.53	10.08	1.44	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	80.92	21.33	5.89	2.94	4.41
dura mater, adult, donor1	10041-101F5	55.50	9.00	1.82	2.06	0.17
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	131.47	8.22	2.22	1.33	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	53.74	19.77	2.72	1.15	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	91.88	11.10	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	49.95	8.78	0.30	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	72.25	13.58	1.23	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	139.23	13.13	1.31	0.00	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	111.62	16.09	2.01	1.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	48.39	6.52	0.36	0.91	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	38.92	4.99	0.48	0.00	0.96
epidermoid carcinoma cell line:A431	10426-106D3	76.03	11.34	0.78	1.45	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	56.20	8.03	0.44	0.99	0.55
epididymis, adult	10197-103E8	86.45	12.14	2.09	1.05	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	25.55	7.81	0.35	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	22.81	2.36	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	67.62	8.52	2.62	1.97	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	52.85	7.97	1.38	2.95	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	53.33	8.63	2.13	3.81	0.90
esophagus, adult, pool1	10015-101C6	58.40	11.04	0.64	2.02	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	44.08	12.02	1.13	1.38	0.00
eye - muscle inferior rectus, donor1	10272-104E2	79.68	7.24	7.24	0.00	4.83
eye - muscle lateral, donor2	10298-104H1	73.65	10.52	0.00	2.10	2.10
eye - muscle medial, donor2	10299-104H2	114.59	17.86	1.49	0.00	1.49
eye - muscle superior, donor2	10297-104G9	92.87	5.73	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	83.07	4.37	4.37	0.00	0.00
eye, fetal, donor1	10054-101G9	46.02	7.63	1.78	2.29	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	54.75	6.54	0.90	0.38	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	128.92	15.43	2.14	2.14	0.95
frontal lobe, adult, pool1	10040-101F4	34.90	10.60	1.69	1.88	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	65.15	9.91	1.50	1.20	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	68.03	15.82	0.00	0.27	0.18
gall bladder, adult	10198-103E9	88.36	12.55	3.38	5.55	1.69
gamma delta positive T cells, donor1	11937-126A2	41.87	18.79	9.66	2.68	1.07
gamma delta positive T cells, donor2	11938-126A3	42.58	15.69	6.72	2.61	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	104.34	9.93	1.69	4.65	3.59
gastric adenocarcinoma cell line:MKN45	10612-108F9	66.15	22.82	8.90	13.73	1.35
gastric cancer cell line:AZ521	10549-107H9	57.22	16.07	0.82	2.30	0.49
gastric cancer cell line:GSS	10560-108A2	42.10	8.24	0.00	1.83	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	125.88	17.36	0.46	1.14	3.43
giant cell carcinoma cell line:LU65	10487-107B1	12.39	8.72	0.34	0.46	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	76.98	10.64	4.06	1.54	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	77.07	14.72	2.24	2.24	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	62.06	10.45	1.69	1.90	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	66.57	11.09	1.40	1.12	0.28
glioblastoma cell line:T98G	10485-107A8	48.67	12.14	4.64	6.51	0.66
glioma cell line:GI-1	10413-106B8	66.19	14.35	3.81	2.64	0.00
globus pallidus - adult, donor10196	10175-103C4	83.10	6.56	2.19	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	131.08	14.65	2.44	3.17	1.22
globus pallidus, adult, donor10258	10367-105F7	86.26	15.06	2.74	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	35.17	5.33	3.73	1.60	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	540.82	117.46	9.79	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	10.45	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	57.28	9.28	0.64	3.20	0.64
hIPS +CCl2, biol_rep1	14383-156B9	68.41	23.41	3.67	1.84	1.84
hIPS +CCl2, biol_rep2	14384-156C1	66.30	16.00	0.91	2.29	1.83
hIPS +CCl2, biol_rep3	14385-156C2	61.19	22.54	3.86	3.86	1.93
hIPS, biol_rep1	14380-156B6	17.25	30.18	4.31	2.87	1.44
hIPS, biol_rep2	14381-156B7	40.47	17.15	1.37	1.37	0.69
hIPS, biol_rep3	14382-156B8	30.90	11.03	1.10	4.41	2.21
hairy cell leukemia cell line:Mo	10712-109I1	75.28	5.75	0.86	0.29	1.44
heart - mitral valve, adult	10205-103F7	82.52	10.16	2.69	2.99	1.49
heart - pulmonic valve, adult	10206-103F8	89.69	12.29	0.78	1.83	2.61
heart - tricuspid valve, adult	10207-103F9	105.75	8.33	4.16	2.50	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	50.20	6.53	0.20	2.45	1.02
heart, adult, diseased, donor1	10051-101G6	66.43	7.66	0.85	1.28	3.41
heart, adult, pool1	10016-101C7	117.06	17.02	0.92	4.37	0.00
heart, fetal, pool1	10046-101G1	64.28	15.92	3.08	5.65	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	33.01	7.40	0.62	1.54	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	180.75	23.78	2.38	4.76	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	87.29	13.15	1.33	2.65	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	102.44	15.05	1.58	4.13	1.34
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	82.76	11.82	2.02	4.04	1.11
hepatoma cell line:Li-7	10484-107A7	79.52	19.57	5.67	14.35	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	107.74	11.06	1.21	0.50	1.31
hippocampus - adult, donor10196	10169-103B7	38.80	8.52	1.89	0.95	4.73
hippocampus, adult, donor10252	10153-102I9	82.25	10.61	0.61	1.63	0.82
hippocampus, adult, donor10258	10374-105G5	14.44	11.45	1.00	0.50	1.49
hippocampus, newborn, donor10223	10363-105F3	31.72	8.46	3.17	1.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	115.97	24.41	0.61	0.61	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	65.19	11.19	1.57	1.57	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	86.32	16.00	2.29	1.02	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	119.54	34.96	2.26	2.82	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	156.22	32.28	1.55	2.58	2.32
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	92.25	31.51	3.04	4.18	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	129.63	35.62	4.67	6.71	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	114.39	23.27	2.80	6.03	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	93.84	30.86	1.67	3.75	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	79.80	23.68	2.13	2.84	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	124.72	19.77	2.09	2.73	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	94.26	28.95	1.35	3.37	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	71.98	10.48	1.41	1.10	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	83.03	10.81	1.97	0.49	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	82.91	9.60	2.62	0.00	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	151.01	35.70	3.05	1.53	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	141.29	30.53	0.44	1.74	3.92
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	150.93	48.98	3.50	1.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	66.31	25.81	4.52	6.41	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	85.49	23.65	3.18	4.09	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	68.60	24.12	2.82	3.76	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	80.34	19.92	1.96	0.82	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	85.35	24.68	1.16	1.45	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	105.82	24.51	3.59	2.39	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	80.18	12.19	3.14	1.11	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	76.46	13.69	2.00	2.00	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	114.74	16.33	3.67	1.63	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	136.96	25.70	5.28	3.52	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	92.49	22.17	1.90	3.17	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	103.80	24.81	2.42	1.82	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	85.33	19.13	3.10	4.65	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	86.34	20.59	3.32	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	83.37	21.81	4.87	3.85	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	93.82	14.32	2.30	2.05	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	107.53	21.96	3.79	3.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	82.00	13.78	4.37	2.35	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	77.52	14.49	1.93	1.45	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	77.99	19.16	2.67	2.23	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	94.15	15.12	2.44	1.46	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	113.69	36.37	1.53	2.75	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	435.93	113.86	26.03	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	119.14	45.01	2.32	3.31	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	101.25	26.82	2.19	4.93	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	95.18	25.33	2.53	5.79	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	66.19	17.44	3.91	3.91	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	76.38	22.67	2.39	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	108.88	27.76	2.57	1.63	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	83.78	19.67	1.62	1.35	1.62
immature langerhans cells, donor1	11904-125F5	102.43	11.38	2.91	0.24	0.00
immature langerhans cells, donor2	11905-125F6	196.45	11.88	3.17	1.58	0.00
insula, adult, pool1	10039-101F3	41.07	13.91	1.32	2.37	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	32.19	4.55	0.00	0.65	0.65
kidney, adult, pool1	10017-101C8	55.37	9.31	2.70	3.00	0.50
kidney, fetal, pool1	10045-101F9	67.27	13.65	4.67	4.24	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	179.51	43.60	4.97	9.80	1.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	27.79	3.59	0.41	0.83	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	39.27	2.94	0.37	2.02	0.18
left atrium, adult, donor1	10079-102A7	54.49	7.08	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	52.08	8.09	0.00	1.52	0.51
leiomyoblastoma cell line:G-402	10721-110A1	80.44	17.51	1.92	3.56	0.55
leiomyoma cell line:10964C	10569-108B2	17.96	5.75	0.36	1.08	1.08
leiomyoma cell line:15242A	10570-108B3	21.74	3.26	1.63	1.09	0.00
leiomyoma cell line:15425	10571-108B4	19.67	3.89	0.49	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	78.42	26.14	1.05	4.18	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	87.48	27.15	18.42	4.84	1.18
liposarcoma cell line:KMLS-1	10782-110G8	29.21	4.53	1.25	0.16	0.94
liposarcoma cell line:SW 872	10726-110A6	114.89	12.06	2.07	2.31	0.24
liver, adult, pool1	10018-101C9	39.87	7.45	2.92	2.59	0.00
liver, fetal, pool1	10086-102B5	25.40	2.82	1.88	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	75.25	12.10	3.50	3.79	0.15
locus coeruleus, adult, donor10252	10165-103B3	68.65	9.04	2.21	1.85	0.55
locus coeruleus, adult, donor10258	10375-105G6	44.30	10.44	1.13	1.41	0.00
locus coeruleus, newborn, donor10223	10362-105F2	69.82	7.99	5.89	0.42	0.42
lung adenocarcinoma cell line:A549	10499-107C4	27.26	5.40	0.83	1.25	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	194.41	52.39	0.69	5.52	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	120.35	17.14	1.32	0.40	1.05
lung, adult, pool1	10019-101D1	63.32	16.07	2.48	2.24	0.35
lung, fetal, donor1	10068-101I5	95.61	32.82	3.14	5.14	0.57
lung, right lower lobe, adult, donor1	10075-102A3	56.36	6.87	3.67	1.83	0.92
lymph node, adult, donor1	10077-102A5	54.44	9.47	0.95	0.95	1.42
lymphangiectasia cell line:DS-1	10727-110A7	153.64	14.03	2.41	0.00	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	125.27	9.21	1.21	0.15	0.15
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	79.85	19.54	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	108.78	11.99	0.44	1.78	0.00
mature adipocyte, donor2	12232-129F9	93.60	10.17	0.42	2.08	0.00
mature adipocyte, donor3	12233-129G1	74.67	11.38	0.95	0.95	0.00
mature adipocyte, donor4	12234-129G2	97.65	19.21	0.53	0.53	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	98.64	24.54	0.71	3.34	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	25.94	3.38	1.13	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	55.54	8.46	1.29	1.29	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	32.09	9.21	1.27	0.95	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	41.80	7.68	13.22	2.56	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	55.86	9.79	1.86	2.03	2.19
medial temporal gyrus, adult, donor10252	10156-103A3	76.40	9.34	2.12	1.91	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	9.63	11.56	1.93	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	301.43	86.12	14.35	0.00	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	33.38	9.69	6.82	2.15	0.36
medulla oblongata - adult, donor10196	10174-103C3	65.55	7.14	1.95	1.30	1.30
medulla oblongata, adult, donor10252	10155-103A2	81.58	11.30	2.01	2.48	0.93
medulla oblongata, adult, pool1	10038-101F2	59.42	14.69	1.47	3.51	0.49
medulla oblongata, newborn, donor10223	10361-105F1	55.90	5.90	1.74	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	232.48	46.94	0.89	0.44	4.43
medulloblastoma cell line:ONS-76	10759-110E3	102.22	12.23	0.86	0.37	1.10
melanoma cell line:COLO 679	10514-107E1	123.33	18.26	5.17	1.15	1.01
melanoma cell line:G-361	10465-106H6	73.02	17.10	1.09	0.81	0.54
meningioma cell line:HKBMM	10691-109F7	90.45	16.82	1.09	0.72	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	218.53	32.60	6.17	11.46	7.05
merkel cell carcinoma cell line:MS-1	10844-111E7	235.12	48.99	4.41	4.15	3.11
mesenchymal precursor cell - adipose, donor1	11747-123G1	56.46	8.59	3.07	1.23	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	45.99	5.64	3.09	2.18	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	26.09	7.45	1.66	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	35.68	4.50	1.55	1.12	1.26
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	41.21	7.51	2.31	1.35	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	44.42	5.55	0.00	2.08	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	29.35	4.12	1.54	0.86	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	42.44	5.98	0.58	1.38	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	40.45	3.58	0.00	0.53	1.06
mesenchymal precursor cell - cardiac, donor4	11755-123G9	47.26	5.00	1.49	0.54	0.68
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	45.24	3.70	1.56	1.14	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	38.53	2.96	0.33	0.99	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	47.05	5.95	0.55	0.42	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	42.59	4.89	2.09	0.35	1.75
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	31.24	4.49	0.41	0.20	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	49.96	6.47	5.03	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	30.21	3.41	0.62	0.31	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	32.83	2.96	0.91	0.23	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	47.83	4.20	2.52	0.84	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	42.59	4.48	0.45	0.60	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	39.74	3.85	0.70	0.61	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	29.82	6.63	1.10	0.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	51.79	7.15	1.14	0.86	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	42.94	5.89	8.84	2.95	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	35.62	2.74	1.83	4.11	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	25.07	5.12	2.05	1.79	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	26.44	5.76	3.40	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	27.42	1.54	2.46	1.85	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	25.65	5.41	0.94	1.88	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	29.78	4.06	2.03	3.38	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	24.76	4.72	1.57	2.36	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.93	2.32	1.39	2.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	30.86	5.19	0.87	3.17	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.76	4.24	2.68	2.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	27.16	4.33	2.16	2.40	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	60.87	9.53	4.40	8.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	18.80	4.70	1.34	1.68	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.97	5.32	1.23	3.28	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	26.20	4.30	3.01	1.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	38.28	5.47	0.00	5.47	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	0.00	0.00	5.16	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	34.75	4.55	4.55	2.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	42.19	2.91	0.00	5.82	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	27.72	5.33	4.80	4.26	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	28.62	3.27	2.45	4.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	27.99	4.28	3.89	3.89	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	56.67	2.10	6.30	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	24.84	4.97	0.99	2.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	57.21	14.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	40.32	5.34	2.37	0.00	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	21.93	1.22	3.66	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.73	5.07	1.27	2.53	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	26.21	5.86	2.76	2.07	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	40.83	2.15	2.15	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	11.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	23.23	4.48	0.41	2.04	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	17.48	3.97	1.59	3.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.10	7.07	0.59	0.00	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	21.51	5.61	0.94	0.31	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	9.36	5.35	1.34	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	24.84	2.37	1.18	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	2.57	0.00	0.00	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	39.24	9.64	0.69	0.69	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	34.14	7.42	0.00	0.49	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	32.52	3.36	0.00	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	31.17	7.63	0.64	3.82	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	28.21	4.03	0.40	0.81	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	32.71	8.72	2.18	2.18	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	32.94	6.34	0.00	2.53	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	33.99	7.89	0.61	1.82	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.83	6.59	2.47	4.12	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	30.95	6.35	0.79	1.98	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	19.79	2.60	0.00	0.97	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	39.73	5.09	0.00	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	195.75	22.44	5.42	5.42	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	30.48	13.94	0.94	0.71	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	66.03	6.26	0.23	0.93	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	46.13	6.37	0.51	0.41	1.54
mesothelioma cell line:Mero-25	10850-111F4	64.23	7.04	4.54	0.68	2.50
mesothelioma cell line:Mero-41	10851-111F5	46.45	6.85	3.18	2.44	0.73
mesothelioma cell line:Mero-48a	10852-111F6	45.84	7.31	0.66	1.33	1.55
mesothelioma cell line:Mero-82	10853-111F7	68.33	4.73	1.84	1.84	0.53
mesothelioma cell line:Mero-83	10854-111F8	49.02	6.13	0.68	0.34	1.87
mesothelioma cell line:Mero-84	10855-111F9	49.80	6.57	1.26	1.52	0.76
mesothelioma cell line:Mero-95	10856-111G1	42.24	5.38	1.45	1.86	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	32.63	3.64	0.83	0.33	1.16
mesothelioma cell line:NCI-H226	10846-111E9	55.20	5.43	0.72	0.36	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	47.83	6.66	1.88	2.39	0.85
mesothelioma cell line:NCI-H28	10845-111E8	51.66	13.49	1.78	1.53	2.29
mesothelioma cell line:No36	10857-111G2	47.63	7.18	0.65	0.98	0.65
mesothelioma cell line:ONE58	10858-111G3	36.04	4.06	1.08	0.81	1.90
migratory langerhans cells, donor1	11901-125F2	79.65	9.02	0.96	0.19	0.77
migratory langerhans cells, donor2	11902-125F3	74.37	7.33	0.61	0.49	0.24
migratory langerhans cells, donor3	11903-125F4	84.71	6.82	0.18	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	57.79	10.12	3.59	2.61	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	86.05	16.53	2.54	2.76	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	72.33	11.75	0.23	1.84	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	47.76	5.14	3.23	0.57	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	92.77	14.41	0.37	0.37	0.74
myeloma cell line:PCM6	10474-106I6	58.71	8.10	0.20	3.76	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	127.84	12.68	2.54	4.06	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	59.23	7.06	0.20	0.78	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	13.26	4.23	0.11	1.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	12.87	3.82	0.29	1.03	0.00
nasal epithelial cells, donor2	12227-129F4	100.46	10.49	1.10	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	79.14	43.02	6.90	8.28	1.15
neuroblastoma cell line:NB-1	10539-107G8	117.86	72.03	3.18	3.55	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	31.00	12.65	0.42	1.48	0.42
neuroblastoma cell line:NH-12	10555-107I6	109.02	36.15	0.93	0.75	1.68
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	48.39	10.20	0.24	0.71	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	80.77	12.35	3.33	4.75	1.58
neuroectodermal tumor cell line:TASK1	10774-110F9	56.35	11.07	1.21	1.41	1.41
neuroepithelioma cell line:SK-N-MC	10728-110A8	140.50	33.06	3.81	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	43.39	5.32	3.19	3.46	0.27
neutrophil PMN, donor1	12133-128D9	327.25	282.62	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	47.35	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	55.81	8.63	32.98	15.05	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	172.11	39.22	0.80	4.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	35.91	4.49	0.64	2.56	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	41.78	4.73	1.31	3.15	1.31
nucleus accumbens, adult, pool1	10037-101F1	41.15	13.12	2.25	1.59	0.19
occipital cortex - adult, donor10196	10172-103C1	57.69	10.30	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	90.17	11.81	1.88	2.68	1.07
occipital cortex, newborn, donor10223	10355-105E4	39.67	8.37	6.91	1.09	0.00
occipital lobe, adult, donor1	10076-102A4	58.25	8.92	2.10	1.57	0.00
occipital lobe, fetal, donor1	10073-102A1	58.36	14.16	2.57	1.72	0.00
occipital pole, adult, pool1	10036-101E9	26.65	9.78	1.02	1.89	0.39
olfactory region, adult	10195-103E6	45.28	7.45	0.76	1.15	1.15
optic nerve, donor1	10277-104E7	172.09	20.01	2.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	62.08	12.53	0.80	1.48	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	46.85	9.75	0.55	0.96	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	73.66	11.18	1.02	1.86	2.20
oral squamous cell carcinoma cell line:SAS	10544-107H4	93.79	13.28	0.69	0.58	2.31
osteoclastoma cell line:Hs 706.T	10704-109H2	62.61	7.35	8.53	6.17	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	321.41	35.50	3.74	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	67.01	18.24	8.27	16.75	1.27
ovary, adult, pool1	10020-101D2	67.96	18.08	1.83	3.06	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	89.64	6.42	3.12	1.28	1.28
pancreas, adult, donor1	10049-101G4	44.21	9.41	1.88	5.64	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	113.21	8.67	0.84	0.00	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	56.56	8.52	0.85	3.07	2.04
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	95.54	12.75	0.00	0.66	0.66
paracentral gyrus, adult, pool1	10035-101E8	33.13	11.26	1.56	1.74	0.55
parietal cortex, adult, donor10258	10373-105G4	45.51	14.68	2.94	0.00	1.47
parietal lobe - adult, donor10196	10171-103B9	41.38	11.29	0.94	4.70	0.94
parietal lobe, adult, donor10252	10157-103A4	59.57	9.98	2.28	1.43	0.29
parietal lobe, adult, pool1	10034-101E7	36.75	11.19	1.50	2.73	0.79
parietal lobe, fetal, donor1	10072-101I9	64.98	27.16	2.91	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	40.00	5.61	11.22	1.12	0.75
parotid gland, adult	10199-103F1	40.08	7.40	1.85	0.00	0.62
penis, adult	10200-103F2	52.10	10.21	2.69	1.07	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	31.24	5.95	2.23	1.12	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	39.77	5.39	0.87	0.87	1.31
pineal gland - adult, donor10196	10179-103C8	118.04	14.19	2.58	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	124.96	17.17	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	84.66	15.05	2.51	1.25	0.63
pituitary gland - adult, donor10196	10180-103C9	53.63	24.28	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	88.60	20.33	1.04	2.08	0.52
pituitary gland, adult, donor10258	10378-105G9	51.07	13.62	0.85	0.85	4.26
placenta, adult, pool1	10021-101D3	49.67	11.93	2.15	1.61	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	92.04	8.34	2.78	0.79	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	86.69	10.12	4.82	9.18	0.47
pons, adult, pool1	10033-101E6	35.63	9.21	2.32	2.24	0.52
postcentral gyrus, adult, pool1	10032-101E5	36.00	9.85	1.39	1.92	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	399.46	96.20	4.18	8.37	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	11.02	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	48.07	5.83	0.44	0.00	1.17
prostate cancer cell line:PC-3	10439-106E7	71.87	10.53	1.27	0.54	0.36
prostate, adult, pool1	10022-101D4	46.62	9.61	1.36	2.63	0.36
putamen, adult, donor10196	10176-103C5	53.35	13.46	4.01	1.89	1.65
putamen, adult, donor10252	10152-102I8	52.94	9.80	3.92	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	32.78	26.23	1.09	3.28	4.37
putamen, adult, donor10258, tech_rep2	10372-105G3	37.45	9.91	2.42	4.59	2.17
putamen, newborn, donor10223	10365-105F5	32.99	3.00	0.75	1.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	143.72	26.77	0.58	4.95	0.29
rectum, fetal, donor1	10067-101I4	116.84	15.30	0.00	4.17	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	65.51	5.72	1.27	0.00	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	15.33	2.49	0.00	0.41	0.41
retina, adult, pool1	10030-101E3	74.35	13.22	1.89	2.88	0.89
retinoblastoma cell line:Y79	10475-106I7	136.92	41.57	0.78	1.30	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	92.95	11.80	1.48	0.61	0.74
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	340.53	87.45	3.09	4.78	1.41
sacrococcigeal teratoma cell line:HTST	10695-109G2	91.70	15.16	3.79	2.27	0.76
salivary acinar cells, donor1	11771-123I7	51.79	4.86	1.29	0.32	1.13
salivary acinar cells, donor2	11772-123I8	57.83	7.57	0.83	2.48	1.38
salivary acinar cells, donor3	11773-123I9	157.57	19.20	2.65	2.65	2.65
salivary gland, adult, pool1	10093-102C3	24.02	9.72	0.00	0.00	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	22.76	9.36	0.59	0.76	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	26.57	9.29	0.59	1.18	0.24
seminal vesicle, adult	10201-103F3	112.69	15.34	3.70	2.12	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	60.49	13.60	0.97	4.13	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	44.29	5.28	1.01	1.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	47.17	7.02	1.00	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	88.79	10.34	0.67	0.81	1.48
signet ring carcinoma cell line:Kato III	10436-106E4	43.66	12.60	1.33	2.87	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	65.93	13.16	0.65	1.81	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	68.10	14.19	1.42	1.42	2.84
skeletal muscle, adult, pool1	10023-101D5	69.32	15.83	0.36	1.92	0.00
skeletal muscle, fetal, donor1	10066-101I3	84.42	8.04	2.01	3.02	0.00
skin, adult, donor1	10074-102A2	61.07	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	97.84	11.36	3.16	2.52	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	106.06	18.01	0.33	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	154.77	39.72	1.58	2.52	6.62
small cell lung carcinoma cell line:DMS 144	10841-111E4	80.57	13.30	2.70	0.77	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	114.72	29.34	1.15	4.45	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	104.71	46.49	1.45	1.29	2.25
small cell lung carcinoma cell line:WA-hT	10562-108A4	55.13	2.83	0.00	0.00	0.65
small intestine, adult, pool1	10024-101D6	48.85	10.87	0.60	1.31	0.12
small intestine, fetal, donor1	10064-101I1	61.67	9.58	0.49	1.23	2.46
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	156.95	26.16	7.18	9.23	1.03
smooth muscle, adult, pool1	10048-101G3	62.80	7.24	1.29	2.84	1.29
somatostatinoma cell line:QGP-1	10781-110G7	66.74	28.41	2.68	3.22	1.07
spinal cord - adult, donor10196	10181-103D1	91.99	8.95	1.84	2.06	1.15
spinal cord, adult, donor10252	10159-103A6	98.17	13.80	1.97	2.37	0.39
spinal cord, adult, donor10258	10369-105F9	62.26	15.22	0.69	1.38	3.46
spinal cord, fetal, donor1	10056-101H2	119.53	17.69	3.05	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	90.92	11.48	5.05	2.30	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	46.75	7.47	9.41	3.14	0.15
spleen, adult, pool1	10025-101D7	57.38	12.34	5.29	1.43	0.33
spleen, fetal, pool1	10044-101F8	57.45	13.98	6.36	2.07	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	59.00	5.59	0.52	0.10	0.52
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	92.28	12.53	0.19	0.76	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	46.48	6.29	0.00	1.75	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	128.62	10.95	0.39	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	36.24	11.14	0.34	0.45	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	62.27	11.44	0.42	2.97	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	50.35	11.85	0.85	0.00	0.00
stomach, fetal, donor1	10062-101H8	104.66	13.88	4.27	0.00	1.07
submaxillary gland, adult	10202-103F4	63.80	10.82	2.85	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	94.92	13.09	1.87	2.91	2.70
substantia nigra, adult, donor10258	10371-105G2	30.52	16.55	2.07	1.55	1.03
substantia nigra, newborn, donor10223	10358-105E7	48.05	7.77	2.83	2.83	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	90.33	23.61	2.98	4.13	1.15
temporal lobe, adult, pool1	10031-101E4	40.35	11.27	1.86	1.53	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	101.85	26.35	0.71	2.14	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	61.10	25.05	3.08	2.20	0.00
tenocyte, donor1	11763-123H8	35.26	2.79	0.70	1.05	2.09
tenocyte, donor2	11765-123I1	18.69	4.20	1.53	1.14	0.38
tenocyte, donor3	11768-123I4	15.57	2.97	1.11	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	91.27	27.19	10.03	5.95	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	119.77	23.58	5.86	11.41	2.00
teratocarcinoma cell line:PA-1	10807-111A6	76.40	14.88	1.70	1.24	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	97.50	17.77	1.65	1.14	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	81.69	26.09	1.89	4.54	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	97.07	26.50	5.78	3.27	1.20
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	154.38	29.64	2.28	0.98	2.61
testis, adult, pool1	10026-101D8	71.62	16.11	5.15	2.47	0.54
testis, adult, pool2	10096-102C6	86.16	26.16	18.49	2.26	5.41
thalamus - adult, donor10196	10168-103B6	71.76	15.46	4.42	1.10	1.10
thalamus, adult, donor10252	10154-103A1	90.49	10.78	1.56	1.88	1.41
thalamus, adult, donor10258, tech_rep1	10370-105G1	21.55	20.02	9.24	3.08	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	45.62	6.42	2.80	1.65	1.48
thalamus, newborn, donor10223	10366-105F6	41.42	5.75	8.05	2.30	0.00
throat, adult	10209-103G2	87.88	11.48	1.50	1.50	0.25
throat, fetal, donor1	10061-101H7	91.11	12.19	4.27	3.35	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	52.07	7.75	0.00	3.18	0.00
thymus, adult, pool1	10027-101D9	141.07	35.79	40.56	2.58	0.89
thymus, fetal, pool1	10043-101F7	96.94	25.35	31.38	1.35	0.83
thyroid carcinoma cell line:KHM-5M	10776-110G2	91.08	11.30	0.80	0.66	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	55.88	9.36	1.68	2.51	0.56
thyroid, adult, pool1	10028-101E1	66.81	10.26	1.31	2.52	0.09
thyroid, fetal, donor1	10060-101H6	86.75	6.86	2.64	2.64	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	117.03	12.32	9.24	3.08	0.00
tongue, adult	10203-103F5	68.84	9.77	0.47	1.63	1.40
tongue, fetal, donor1	10059-101H5	54.78	8.28	0.79	3.15	0.39
tonsil, adult, pool1	10047-101G2	59.60	14.02	5.81	0.70	0.30
trachea, adult, pool1	10029-101E2	58.98	11.62	1.31	1.23	0.33
trachea, fetal, donor1	10058-101H4	64.24	4.23	0.38	2.31	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	44.64	6.73	1.42	3.19	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	85.41	10.13	0.41	0.61	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	89.31	21.15	1.25	2.66	0.63
tridermal teratoma cell line:HGRT	10694-109G1	197.86	13.32	7.61	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	32.42	7.11	0.59	2.12	0.25
umbilical cord, fetal, donor1	10057-101H3	66.77	8.35	2.09	2.09	2.09
uterus, adult, pool1	10100-102D1	59.55	18.26	4.10	3.41	0.34
uterus, fetal, donor1	10055-101H1	78.33	8.70	2.05	1.54	0.51
vagina, adult	10204-103F6	51.70	4.52	0.00	1.29	0.00
vein, adult	10191-103E2	80.88	12.06	12.49	1.53	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	61.15	5.34	0.00	0.27	0.80